Amedeo Smart

Free Medical Literature Service

 

Amedeo

Anemia
  Free Subscription

Articles published in
Hemoglobin
    January 2026
  1. RAO H, Li P
    Risk Factors for Anemia in Silent Carrier or Minor alpha-Thalassemia.
    Hemoglobin. 2026 Jan 25:1-5. doi: 10.1080/03630269.2026.2615739.
    >> Share

  2. YAGMUR I, Belge Kurutas E, Oner E
    Alterations in Serum MAO Activity and Tau Levels in beta-Thalassemia.
    Hemoglobin. 2026;50:61-68.
    >> Share

  3. XIE Q, Yan T, Ying Z, Fu Y, et al
    Two Novel SUPT5H Variants Causing beta-Thalassemia Trait Phenotypes.
    Hemoglobin. 2026;50:86-89.
    >> Share

  4. FJELD B, Jorgensen M, Lillemoen PKS, Holstad K, et al
    Mild Thalassemic Effect of Heterozygous Hb Sogn in a Large Cohort from Routine Hemoglobinopathy Investigation.
    Hemoglobin. 2026;50:49-55.
    >> Share

    November 2025
  5. YANG A, Huang TL, Song CY, Xiao ZG, et al
    Nonsense Variant in the beta-Spectrin Gene Causing Hereditary Spherocytosis Identified by Whole-Exome Sequencing in a Child.
    Hemoglobin. 2025;49:439-443.
    >> Share

  6. QIN L, Li X, Wang Y, Niu C, et al
    Identification of a Patient with Transfusion-Dependent beta-Thalassemia Caused by Compound Heterozygous Mutations of HBB: C.84_85insC and Common Linked Intronic Variants in HBB.
    Hemoglobin. 2025;49:429-434.
    >> Share

  7. TEE PH, Tuan Mahmood TM, Tan S
    A Cross-Sectional Study on Pain and Quality of Life of Adult Patients with Transfusion-Dependent Thalassemia in a Tertiary Hospital In Malaysia.
    Hemoglobin. 2025;49:399-407.
    >> Share

  8. TATU T, Klasamut S, Sorntham H, Chantanaskulwong P, et al
    Predicting the Double Heterozygotes of HbE and alpha-Thalassemia-1 (Southeast Asian Type) Using RapidMiner-Generated Hematologic Algorithm.
    Hemoglobin. 2025;49:390-398.
    >> Share

  9. ZHOU L, Huang X, Xiao W, Liu Z, et al
    Genetic Analysis and Clinical Relevance of HBA1:c.305T > C (Leu > Pro): A Novel Variant Linked to alpha-Thalassemia.
    Hemoglobin. 2025;49:424-428.
    >> Share

  10. MASOOD KHAN MT, Ul Haq I, Ali A, Ul Haq I, et al
    Genetically Confirmed Dual Hematologic Disorder: A Case of beta-Thalassemia with Frameshift Mutation and Type 3 von Willebrand Disease in a Pediatric Patient.
    Hemoglobin. 2025;49:421-423.
    >> Share

  11. PRAYALAW P, Prajantasen T
    A Diverse Genetic Landscape: Thalassemia Genotype Patterns in Myanmar and Cambodian Workers in Southern Thailand.
    Hemoglobin. 2025;49:384-389.
    >> Share

  12. OKUR ACAR S, Gurcinar M, Acar S, Koprulu O, et al
    Pituitary Versus Hepatic Iron Assessment in Transfusion-Dependent Thalassemia: Is Signal Intensity Ratio a Reliable Tool?
    Hemoglobin. 2025;49:377-383.
    >> Share

  13. RUN G, Jiang Y, Xu J, Jiang C, et al
    Genotypic Characterization of Thalassemia in Huadu District, Guangzhou, China: A Single-Center Retrospective Study.
    Hemoglobin. 2025;49:371-376.
    >> Share

  14. SHEAN R, Deshmukh N, Palmer M, Agarwal A, et al
    Utility of Molecular Sequencing and Hematologic Parameters for Diagnosis of alpha-Thalassemia: A Perspective of the National Reference Laboratory.
    Hemoglobin. 2025;49:414-420.
    >> Share

    September 2025
  15. DEHURY S, Mohanty PK, Das K, Meher S, et al
    Influence of Alpha Thalassaemia on Hematological and Clinical Presentations in Patients of Sickle Cell-beta-Thalassaemia with IVS I-5 (G-->C) Mutation (HBB: C.20A > T/HBB: C.92 + 5G > C).
    Hemoglobin. 2025;49:309-316.
    C) Mutation (HBB: C.20A > T/HBB: C.92 + 5G > C).&body=DEHURY S, Mohanty PK, Das K, Meher S, et al. Influence of Alpha Thalassaemia on Hematological and Clinical Presentations in Patients of Sickle Cell-beta-Thalassaemia with IVS I-5 (G-->C) Mutation (HBB: C.20A > T/HBB: C.92 + 5G > C). Hemoglobin. 2025;49:309-316. https://pubmed.ncbi.nlm.nih.gov/41170940" ALT="Email" TITLE="Email"> --> >> Share

  16. BHAYANA S, Chakaroborty S, Nathany S, Danewa A, et al
    Encouraging Outcomes of Hematopoeitic Stem Cell Transplantation in Pediatric Sickle Cell Disease- A Decade-Long Experience from the Developing World.
    Hemoglobin. 2025;49:317-322.
    >> Share

  17. OSMAN TJ, Karim AH, Khailany RA, Mohammed KA, et al
    Hemoglobin Dieppe (HBB:c. 383A > G): A Rare Dominant beta-Thalassemia in an Iraqi Kurdish Family.
    Hemoglobin. 2025;49:366-369.
    >> Share

  18. LOONAT S, Naran N, Ramparsad N, Beringer N, et al
    Sickling Disorder Caused by Co-Inheritance of Hemoglobin Maputo and Hemoglobin S: Case Report and Review of the Literature.
    Hemoglobin. 2025;49:326-331.
    >> Share

  19. DEVI TR, Dange P, Deka R, Chetia R, et al
    HbH Disease in an Elderly Man Due to Compound Heterozygosity for Deletional alpha-Thalassemia and Hb Dubai (HBA2:c.368A > T).
    Hemoglobin. 2025;49:354-357.
    >> Share

  20. FERRER BENITO S, Ortega Montero B, Martinez Nieto J, Muruzabal Sitges MJ, et al
    An HBB Intron 1 Variant (c.92 + 9C > T) Suggestive of beta-Thalassemia Trait.
    Hemoglobin. 2025;49:358-360.
    >> Share

  21. GAN H, Yu H, Hara H, Li T, et al
    The Risk of Rapid Deterioration of Sepsis in the Patient with Non-Transfusion-Dependent Thalassemia: A Case Report.
    Hemoglobin. 2025;49:347-353.
    >> Share

  22. FAWAZ H, Hodroj MH, Charbel N, El Khoury S, et al
    Therapeutic Response to Hydroxyurea in Beta-Thalassemia Intermedia with Rare Mutation: A Case Report.
    Hemoglobin. 2025;49:342-346.
    >> Share

  23. RODRIGUEZ-NORIEGA BEJAR L, Simon Bernaldo de Quiros C, Gonzalez Muniz S, Gutierrez Martinez R, et al
    Coexistence of Mycoplasma Pneumonia and Pulmonary Embolism as a Cause of Acute Chest Syndrome in a Child with Sickle Cell Disease.
    Hemoglobin. 2025;49:332-336.
    >> Share

    July 2025
  24. MARHATTA A, Choudhuri J, Mulvey JJ, Campbell S, et al
    When Unstable Hemoglobin Lansing Interacts with Alpha Thalassemia Along with HbS: An Interesting Case with Unique Clinical Presentation.
    Hemoglobin. 2025;49:305-308.
    >> Share

  25. MUANGPA S, Jermnim S, Charoenporn P, Suannum P, et al
    Detection of Common alpha-Hemoglobin Variants in Thailand by Using Real-Time PCR with High Resolution Melting Analysis.
    Hemoglobin. 2025;49:257-267.
    >> Share

  26. LI W, Wei G, Ren S, Xie Z, et al
    HBA2: C.4delG: A Novel Frameshift Mutation Causing alpha(+)-Thalassemia Found in a Chinese Family.
    Hemoglobin. 2025;49:301-304.
    >> Share

  27. LIU P, Wang J, Luo H, Tang XW, et al
    A Novel Large Deletion Including the Major Regulatory Element Compounded with SEA Deletion Causing Hydrops-Fetalis-Syndrome.
    Hemoglobin. 2025;49:289-293.
    >> Share

  28. YE L, Li W, Wei G, Shen X, et al
    Misdiagnosis of alpha-Thalassemia Heterozygotes as Homozygotes Due to Base Mutations in the Primer Binding Region.
    Hemoglobin. 2025;49:237-243.
    >> Share

  29. AMINI MA, Afgar A, Daneshi Cohan S, Soleimani S, et al
    Association of Micro RNA-155 with Alloimmunization in Transfusion-Dependent Thalassemia Patients.
    Hemoglobin. 2025;49:268-274.
    >> Share

  30. HUANG X, Shi L, Lai Y, Li J, et al
    KLF1 Knockdown Differentially Regulates gamma-Globin Expression: Inhibition in K562 Cells but Reactivation in beta-Thalassemia Major Erythrocytes with Erythropoiesis Disruption.
    Hemoglobin. 2025;49:244-251.
    >> Share

  31. OGGIONNI M, Manenti B
    Hereditary Persistence of Fetal Hemoglobin (HPFH): Detection of Unknow (A)gamma-Globin Promoter Mutation at the C2H2 Zinc Finger Transcription Factors Binding Sites.
    Hemoglobin. 2025;49:298-300.
    >> Share

    May 2025
  32. DIXIT A, Hegde A, M S R
    Clinical Implications of HbD-Punjab and HbS co-Inheritance - A Rare Case in South India.
    Hemoglobin. 2025;49:208-212.
    >> Share

  33. SHAMOON M, Mahmood R, Bozdar M, Yousof S, et al
    Unraveling Hemoglobin D's Influence: A Comprehensive Analysis of Clinicopathological Parameters in Hemoglobin D Patients.
    Hemoglobin. 2025;49:195-199.
    >> Share

  34. RUENGDIT C, Punyamung M, Maneewong K, Khamphikham P, et al
    Characterization of HbH Disease Caused by Compound Heterozygotes alpha(+)-Thalassemia 3.7 kb Deletion and a Large Novel alpha(0)-Thalassemia Deletion.
    Hemoglobin. 2025;49:229-232.
    >> Share

  35. AKBARNATAJ H, Eghbali A, Ashayeri N, Padooiy Nooshabadi M, et al
    Evaluating Renal Glomerular Function in Beta-Thalassemia Patients Receiving Deferasirox Using Serum Cystatin-C and Creatinine: A Cross-Sectional Study.
    Hemoglobin. 2025;49:178-186.
    >> Share

  36. TIWARI A, Rao E, Suresh I, Tiwari M, et al
    Hepatobiliary Manifestations in Thalassemia Patients: A Narrative Review.
    Hemoglobin. 2025;49:200-207.
    >> Share

  37. JAJODIA E, Arora N, Haque M, Ganguly T, et al
    Heterozygous Beta Thalassemia with Segmental Duplication of chr16p13.3 Leading to Thalassemia Intermedia Phenotype: A Report of 2 Cases with Review of Literature.
    Hemoglobin. 2025;49:222-228.
    >> Share

  38. RODRIGUEZ DE LA CRUZ NJ, Mengana Torres Y, Garcia Naranjo JC, Ricardo Ferro BT, et al
    Dynamic Viscosity of Hemoglobin Solutions Determined by Transverse Proton Magnetic Relaxation.
    Hemoglobin. 2025;49:172-177.
    >> Share

  39. RAMSAY Z, Sharma D, Wisdom-Phipps M, Chin N, et al
    Estradiol is Pro-Nociceptive and Associated with a Small-Fiber Neuropathy Among Premenopausal Women with Sickle Cell Disease.
    Hemoglobin. 2025;49:161-171.
    >> Share

  40. COOMER CA, Levin RA, Neri CM
    Death from S. pneumoniae in HbSC Disease: Was Expanded Pneumococcal Vaccination Too Late?
    Hemoglobin. 2025;49:213-217.
    >> Share

    March 2025
  41. USSHER FA, Laing EF, Kontor EK, Atta-Owusu AB, et al
    Haplotype-Specific Genetic Epidemiology of Sickle Cell Anemia Patients in Accra, Ghana: Patterns, Clinical Implications, and Public Health Responses.
    Hemoglobin. 2025 Mar 5:1-9. doi: 10.1080/03630269.2025.2474609.
    >> Share

  42. FORTE S, Couette M, Oudin Doglioni D, Desmarais P, et al
    Educational Bias in Cognitive Screening of Adults with Sickle Cell Disease: A Bilingual Multisite Observational Study.
    Hemoglobin. 2025;49:156-159.
    >> Share

  43. HUANG YY, Ye LH, Li W, Wei GX, et al
    Prevalence and Molecular Characteristics of Hemoglobin Variants in Laibin City, Central Guangxi of Southern China.
    Hemoglobin. 2025;49:94-102.
    >> Share

  44. NIK MOHD HASAN NFF, Achour A, Koopmann T, Gammeren AV, et al
    Unusual Causes of beta Thalassemia Trait: Discovery of another Three Novel SUPT5H Variants.
    Hemoglobin. 2025;49:145-148.
    >> Share

  45. XU Y, Luo H, Huang T, Fang Y, et al
    Molecular Characterization of Complex Thalassemia with Multiple Variants in beta-Globin Gene Cluster and the Identification of a Novel Structural Rearrangement in gamma-Globin Gene.
    Hemoglobin. 2025;49:149-152.
    >> Share

  46. JOMOUI W, Tepakhan W
    Rapid and Visual Molecular Detection of High Hb F Determinants; HPFH6, Asian Indian inv-del ((A)gammadeltabeta)(0)-Thalassemia, and Thai del-inv-ins ((A)gammadeltabeta)(0)-Thalassemia Using LAMP Colorimetric Phenol Red Assays.
    Hemoglobin. 2025;49:103-110.
    >> Share

  47. BAZI A, Khanahmad A, Khazaee-Nasirabadi MH, Pirouzbakht M, et al
    Long-Term and Transient Calcium Channel Blockers; A Systematic Review of Their Role in the Management of Cardiomyopathy in Transfusion-Dependent Thalassemia.
    Hemoglobin. 2025;49:111-125.
    >> Share

  48. AL-ALLAWI N, Al-Mousawi MM, Al Allawi S, Ibrahim KJ, et al
    Alloimmunization in beta-Thalassemia and Sickle Cell Disease in Middle Eastern Countries: A Systemic Review.
    Hemoglobin. 2025;49:126-140.
    >> Share

  49. MISHRA V, Singh Yadav P, Singh R, Rainchwar S, et al
    Evaluating Health-Related Quality of Life in Thalassemia: Low-Dose Thalidomide vs. Standard Care-Insights from a Comparative Study.
    Hemoglobin. 2025;49:78-84.
    >> Share

  50. RODCHAPROM P, Fanhchaksai K, Maneekesorn S, Kittisakmontri K, et al
    Prevalence and Associated Factors of Zinc and Vitamin D Deficiencies in Pediatric and Young Adult Patients with Non-Transfusion-Dependent Thalassemia.
    Hemoglobin. 2025;49:73-77.
    >> Share

    January 2025
  51. WINGER BA, Ajayi A, Vichinsky E
    Diagnosis and Treatment of Alpha Thalassemia Major.
    Hemoglobin. 2025;49:3-9.
    >> Share

  52. HAMBLETON I, Mason K, Serjeant B, Serjeant G, et al
    Hypersplenism Affects Growth and Haematology in HbSS: Observations from the Jamaican Birth Cohort.
    Hemoglobin. 2025;49:47-53.
    >> Share

  53. ALOOFY TA, Aleem A, Algahtani FH, Al-Shehri A, et al
    Long-Term Survival Rates of a Sickle Cell Disease Cohort in Saudi Arabia: A 2009-2023 Observational Study.
    Hemoglobin. 2025;49:54-59.
    >> Share

  54. TEPAKHAN W, Attakan N, Kanjanaopas S, Srewaradachpisal K, et al
    Rapid Identification of beta-Thalassemia, Hb E, and High Hb F Determinants Using a High-Resolution Melting Analysis: Application in Prenatal Diagnosis in Southern Thailand.
    Hemoglobin. 2025;49:38-46.
    >> Share

  55. TANG B, Chen K, Liang L, Li J, et al
    Characterization and Confirmation of Mildly Unstable Hb Pontoise or alpha1 63(E12) Ala > Asp and Literature Review.
    Hemoglobin. 2025;49:26-30.
    >> Share

  56. SUALI L, Mohammad Salih FA, Ibrahim MY, Bin Jeffree MS, et al
    The Effect of Single Nucleotide Polymorphisms on Clinical Phenotypes of Sabahan Transfusion-Dependent beta-Thalassemia Patients with Homozygous Filipino beta(0)-Deletion.
    Hemoglobin. 2025;49:10-19.
    >> Share

  57. ZENG GK, Yang YF, Ge YY, Yang Y, et al
    Identification of a beta-Globin Gene Mutation with the Genotype beta-28(A > G), IVS-I-5(G > A)/betaCD 71/72(+A) Using Third-Generation Sequencing.
    Hemoglobin. 2025;49:63-68.
    >> Share

  58. HASSAN MK, Abbas RA, Hassan RA, Taghlubee IM, et al
    Prevalence and Spectrum of beta-Thalassemia Mutations in Baghdad, Iraq: Data from the Premarital Screening Program.
    Hemoglobin. 2025;49:31-37.
    >> Share

  59. SEGUNMARU Z, Bayo F, Tobias AJ, Wingate LT, et al
    Knowledge of Sickle Cell Disease, Awareness of Sickle Cell Trait Status and Its Impact on Relationships Among Students at a Historically Black College.
    Hemoglobin. 2025;49:20-25.
    >> Share

  60. ZHOU JY, Wang CY, Li J, Chen GL, et al
    First Reported Case of Hemoglobin H Disease Caused by the Rare alpha-Globin Gene Mutation (HBA2 c.244delT) in a Chinese Family.
    Hemoglobin. 2025;49:69-71.
    >> Share

    December 2024
  61. MAKALO L, Adegoke SA, Allen SJ, Kuti BP, et al
    Sociodemographic and Clinical Factors Predictive of Poor Health-Related Quality of Life of Children with Sickle Cell Anemia in The Gambia.
    Hemoglobin. 2024 Dec 18:1-9. doi: 10.1080/03630269.2024.2440030.
    >> Share

    November 2024
  62. DRYLLIS G, Russo R, Andolfo I, Iolascon A, et al
    Hereditary Hemolytic Anemia Due to PIEZO1 Red Blood Cell Membrane Defect.
    Hemoglobin. 2024 Nov 26:1-3. doi: 10.1080/03630269.2024.2427187.
    >> Share

  63. NING S, Qin Y, Xie Y, Liang Y, et al
    The First Compound Heterozygosity for Two Different alpha-Thalassemia Determinants Causes Hb Bart's Hydrops Fetalis in a Chinese Family.
    Hemoglobin. 2024;48:384-388.
    >> Share

  64. TAN L, Huang T, Luo L, Ma P, et al
    Molecular Identification and the Hematological Findings of Four Novel Variants in Globin Genes in Jiangxi Province of Southern China.
    Hemoglobin. 2024;48:369-374.
    >> Share

  65. ASKARIAN-SARDARI F, Esmaeilian S, Hajimohammadi Z, Hayat-Nosaeid M, et al
    The Most Common Types of 3.7 Kilobase Deletion in the Iranian Population.
    Hemoglobin. 2024;48:365-368.
    >> Share

    September 2024
  66. YE LH, Huang YY, Zhu ZT, Jiang AQ, et al
    alpha(0)-Thalassemia Caused by a Novel alpha-Globin Gene Cluster Deletion (-(LB)) Found in a Chinese Family.
    Hemoglobin. 2024;48:341-345.
    >> Share

  67. KARNPEAN R, Tepakhan W, Rungruang K, Pongpatchara P, et al
    The Validation of Whole beta-Globin Gene Sequencing for Detecting beta-Thalassemia Mutations Found in Thailand Using Next-Generation Sequencing (NGS).
    Hemoglobin. 2024;48:333-340.
    >> Share

  68. MAMMADOVA T, Asadov C, Alimirzoyeva Z, Abdulalimov E, et al
    Update on Prevention of Hemoglobinopathies in Azerbaijan.
    Hemoglobin. 2024;48:353-356.
    >> Share

  69. LIANG JL, Ge YY, Xie LX, Zeng GK, et al
    Phenotypic Analysis of the HBA2: C.95 G > A Mutation in China.
    Hemoglobin. 2024;48:329-332.
    >> Share

  70. ROMADHON PZ, Ashariati A, Bintoro SUY, Suryantoro SD, et al
    Existing Tubular Injury in beta-Thalassemia Major Patients Receiving Iron Chelating Agents with Normal Creatinine Level in East Java, Indonesia.
    Hemoglobin. 2024;48:301-307.
    >> Share

  71. GUINDO A, Koya A, Sarro YDS, Toure AB, et al
    Analysis of Iron Status in Sickle Cell Disease Patients During Steady State at the Center de Recherche et de Lutte contre la Drepanocytose (CRLD) Bamako.
    Hemoglobin. 2024;48:314-318.
    >> Share

  72. ABBAS RA, Hassan RH, Taghlubee IM, Mohammed SI, et al
    Prevalence and Molecular Characterization of beta-Thalassemia in Kirkuk Province of Northern Iraq.
    Hemoglobin. 2024;48:308-313.
    >> Share

  73. GIUBBILEI C, D'Angelo S, Fotzi I, Mogni M, et al
    deltabeta-Thalassemia and alpha-Triplication: Is Genetic Retesting Worthwhile in Case of Non-Coherent Phenotype?
    Hemoglobin. 2024;48:349-352.
    >> Share

    July 2024
  74. RASLAN IA, Solh Z, Kuo KHM, Abdulrehman J, et al
    Venous Thromboembolism in Individuals with Sickle Cell Disease: A Narrative Review.
    Hemoglobin. 2024;48:231-243.
    >> Share

  75. TAVASSOLI S, Chung JH, Panigrahi AR, Shahsavar A, et al
    Hemoglobin Balkh, a Novel Mutation in Codon 132 of alpha2-Globin Gene [alpha132(H15) (+T) or HBA2:C.396dup (p.Val134fs)]: A Case Report and Insight into the Pathophysiology.
    Hemoglobin. 2024;48:280-284.
    >> Share

  76. YALCIN N, Sadri S, Ertinmaz Ozkan A, Gursoy V, et al
    Elevated Plasma Atherogenic and Triglyceride-Glucose Indices: Markers of Cardiovascular Risk in Transfusion-Dependent Thalassemia.
    Hemoglobin. 2024;48:292-300.
    >> Share

  77. SERJEANT BE, Mason K, Reid M, Hambleton I, et al
    The Aplastic Crisis in HbSS: Observations from the Jamaican Birth Cohort.
    Hemoglobin. 2024;48:274-279.
    >> Share

  78. POH KY, Bee PC
    First Report of Hb Youngstown in Capillary Electrophoresis and Overlapping Hb Analysis Findings with Hb Rush.
    Hemoglobin. 2024;48:254-257.
    >> Share

  79. SONGDEJ D, Kadegasem P, Sirachainan N, Ruengdit C, et al
    The First Thai Case of Nondeletional HbH Disease Caused by Compound Heterozygosity for alpha-Thalassemia-1 Chiang Rai (--(CR)) Type Deletion with Hb Constant Spring.
    Hemoglobin. 2024;48:261-264.
    >> Share

  80. COSKUN C, Unal S
    Dominant Beta Thalassemia: A Very Rare Cause of Thalassemia in a Mediterranean Country.
    Hemoglobin. 2024;48:258-260.
    >> Share

  81. KEITA M, Seck M, Diallo AB, Toure SA, et al
    Morbidity and Mortality Associated with COVID-19 and Acute Chest Syndrome in Sickle Cell Disease Patients.
    Hemoglobin. 2024;48:285-291.
    >> Share

  82. JIANG F, Huang S, Liu T, Wang J, et al
    Identification of a Novel 16.8Kb Deletion of the alpha-Globin Gene Cluster by Third-Generation Sequencing.
    Hemoglobin. 2024;48:244-249.
    >> Share

  83. DA SILVA ARAUJO A, Silva Pinto AC, de Castro Lobo CL, Figueiredo MS, et al
    Sickle Cell Disease in Brazil: Current Management.
    Hemoglobin. 2024;48:218-230.
    >> Share

    June 2024
  84. CHIGUER A, Lyahyai J, El Kadiri Y, Cherkaoui Jaouad I, et al
    Clinical Exome Sequencing Reveals Novel Mutations in SPTB Gene Associated with Hereditary Spherocytosis in Patients with Suspected Congenital Hemolytic Anemia.
    Hemoglobin. 2024 Jun 4:1-4. doi: 10.1080/03630269.2024.2360456.
    >> Share

    May 2024
  85. RAO E, Patel D, Saxena N, Saha KB, et al
    Ameliorating Mental Health Issues in Sickle Cell Disease Patients: A Viewpoint.
    Hemoglobin. 2024;48:212-213.
    >> Share

  86. ASRI AS, Samsuddin MH, Jalil N, Mohamad Tahir N, et al
    Characterization of Hemoglobin Malay Phenotypes in Tertiary Hospitals.
    Hemoglobin. 2024;48:153-160.
    >> Share

  87. SINGH R, Halder R, Hemant Gupta V, Rainchwar S, et al
    ATG-Thymoglobulin Versus ATG-Fresenius for Conditioning in Thalassemia Patients Who Underwent Allogenic Stem Cell Transplantation from Matched-Sibling Donor: A Tertiary Cancer Care Center Short-Term Experience.
    Hemoglobin. 2024;48:186-191.
    >> Share

  88. YAO C, Chen L, Ma J, Li N, et al
    A Novel Frameshift Mutation of HBB Causing Dominant beta-Thalassemia in a Chinese Individual.
    Hemoglobin. 2024;48:182-185.
    >> Share

  89. BHATTACHARJEE S, Ghosh S, Shaw J, Bhattacharjee S, et al
    Thalidomide and Hydroxyurea in Transfusion-Dependent Thalassemia: Efficacy, Safety Profile and Impact on Quality of Life.
    Hemoglobin. 2024;48:161-168.
    >> Share

  90. ADEGOKE SA, Makalo L, Sallah A, Saine H, et al
    Point-of-Care Newborn Screening for Sickle Cell Disease at Selected Health Facilities in the Gambia.
    Hemoglobin. 2024;48:169-174.
    >> Share

  91. RAVICHANDRAN S, Hoffmann M, Petersen J, Sjo L, et al
    A Rare Case of De Novo Beta-Thalassemia Diagnosed by Whole-Genome Sequencing in an Ethnically Danish Newborn.
    Hemoglobin. 2024;48:196-199.
    >> Share

  92. IBRAHIM L, Gwarzo DH, Yusuf AA
    Secretory Phospholipase A2 Levels Are High in Women with Sickle Cell Disease and Menstruation-Induced Vaso-Occlusive Crises.
    Hemoglobin. 2024;48:175-181.
    >> Share

  93. HE X, Tian P, Zhong L, Peng S, et al
    A Novel 165 Kb Duplication Involving the alpha-Globin Gene Cluster Is Identified by Low-Pass Whole Genome Sequencing in a Chinese Thalassemia Intermedia Patient.
    Hemoglobin. 2024;48:203-208.
    >> Share

  94. PAN L, Wang Y, Lin H, Zhang X, et al
    A Novel Frameshift Mutation(HBA2:C.337delC) Associated With alpha-Thalassemia Trait Detected by Next-Generation Sequencing in Southern China.
    Hemoglobin. 2024;48:200-202.
    >> Share

    April 2024
  95. KUMARI A, Chauhan G, Chaudhuri PK, Kumari S, et al
    Genetic Variants Associated with the Risk of Stroke in Sickle Cell Anemia: Systematic Review and Meta-Analysis.
    Hemoglobin. 2024 Apr 18:1-12. doi: 10.1080/03630269.2024.2340685.
    >> Share

    March 2024
  96. LIU D, Nong X, Lai F, Nong C, et al
    Noninvasive Prenatal Diagnosis of SEA-Thalassemia by Combining 1000 Genomes Database and Relative Haplotype Dosage.
    Hemoglobin. 2024;48:71-78.
    >> Share

  97. VOUSVOUKI M, Delaki EE, Boutou E, Yfanti E, et al
    A New alpha1-Globin Variant, Hb Ormylia [HBA1:c.63C > G; p.His21Gln]. Report of Eleven Cases in Northern Greece.
    Hemoglobin. 2024;48:133-137.
    >> Share

  98. ASSAF N, El Zibaoui R, Monsef C, Abi Nassif T, et al
    Severe Transfusion-Dependent Thalassemia in Compound Heterozygote Palestinian Siblings with Two alpha-Globin Gene Defects, Hb Taybe D HBA1: C.119_121delCCA Mutation and HBA2: C.*94A > G Mutation.
    Hemoglobin. 2024;48:129-132.
    >> Share

  99. CHIN N, Asnani M
    Poor Sleep Quality in Jamaican Adults With Sickle Cell Disease: Prevalence, Risk Factors, and Association With Quality of Life.
    Hemoglobin. 2024;48:87-93.
    >> Share

  100. WAYE JS, Hanna M, Hohenadel BA, Nakamura L, et al
    Newborn Screening for beta-Thalassemia Identifies a Complex Genotype Involving a Novel beta-Globin Gene Mutation (HBB:c.336dup).
    Hemoglobin. 2024;48:113-115.
    >> Share

  101. AL-ALLAWI N, Atroshi SD, Sadullah RK, Eissa AA, et al
    A Population-Oriented Genetic Scoring System to Predict Phenotype: A Pathway to Personalized Medicine in Iraqis With beta-Thalassemia.
    Hemoglobin. 2024;48:94-100.
    >> Share

  102. WAYE JS, Hanna M, Nakamura L, Walker L, et al
    Splice Acceptor Mutation [HBB:c.93-2A > T] in a Patient with Hb S/beta(0)-Thalassemia.
    Hemoglobin. 2024;48:116-117.
    >> Share

    February 2024
  103. JIANG H, Li DZ
    Early Onset of Severe Anemia Caused by Hb Calgary (HBB: C.194G > T): Another Case Report.
    Hemoglobin. 2024 Feb 12:1-3. doi: 10.1080/03630269.2024.2315188.
    >> Share

    January 2024
  104. KHOSHNAW NSH, Omar JJ, Hussein ZS, Mohammed RN, et al
    Premarital Screening is Pivotal in Reducing the Births of Babies Affected with Thalassemia Major in Iraq.
    Hemoglobin. 2024;48:56-59.
    >> Share

  105. WAYE JS, Hanna M, Hohenadel BA, Nakamura L, et al
    beta(0)-Thalassemia Caused by a Novel Nonsense Mutation [HBB:c.199A > T].
    Hemoglobin. 2024;48:69-70.
    >> Share

  106. CHUANSUMRIT A, Songdej D, Sirachainan N, Kadegasem P, et al
    Efficacy and Safety of a Dispersible Tablet of GPO-Deferasirox Monotherapy among Children with Transfusion-Dependent Thalassemia and Iron Overload.
    Hemoglobin. 2024;48:47-55.
    >> Share

  107. DESAI G, Dave K, Devare S, Desai S, et al
    Ethical and Clinical Considerations in the Use of Hydroxyurea in Pregnant Women with Sickle Cell Disease.
    Hemoglobin. 2024;48:66-68.
    >> Share

  108. WU SM, Li C, Huang SR, Jiang F, et al
    A 6-Year Follow-up of a Chinese Child with Homozygous beta(0)-Thalaasemia and a Heterozygous KLF1 Mutation.
    Hemoglobin. 2024;48:60-62.
    >> Share

  109. DE OLIVEIRA TAQUES W, Bett GC, de Moraes BLB, Medeiros I, et al
    Factors Associated with Overt Stroke in Children and Adolescents with Sickle Cell Disease: A Retrospective Cohort Study.
    Hemoglobin. 2024;48:39-46.
    >> Share

  110. MAMATA M, Padma G, Pragna Laxmi T, Saroja K, et al
    Identification of a Novel Variant c.163delG in HBB Gene Resulting in a Beta Null Phenotype in a Proband with Thalassemia Intermedia.
    Hemoglobin. 2024;48:1-3.
    >> Share

  111. LADU AI, Kadaura MU, Dauda M, Baba AS, et al
    Malaria Infection in Patients with Sickle Cell Disease in Nigeria: Association with Markers of Hyposplenism.
    Hemoglobin. 2024;48:15-23.
    >> Share

  112. ZHENG LH, Liang L, Bai JP, Liao HX, et al
    Misdiagnosis of beta-Thalassemia Major Due to Chinese (G)gamma+((A)gammadeltabeta)(0)-Thalassemia Combined with beta(0)-Thalassemia.
    Hemoglobin. 2024;48:24-29.
    >> Share

  113. CHEN M, Lv A, Zhang S, Zheng J, et al
    First Report of Filipino beta(0)-Thalassemia/beta-Thalassemia in a Chinese Family.
    Hemoglobin. 2024;48:34-38.
    >> Share

    November 2023
  114. SILVA BORBOREMA T, Moreira Brito JC, Lima Batista EM, Siqueira Batista R, et al
    Case Fatality Rate and Severity of COVID-19 among Patients with Sickle Cell Disease: A Systematic Review and Meta-Analysis.
    Hemoglobin. 2023;47:85-96.
    >> Share

  115. SAEIDNIA M, Fazeli P, Farzi A, Atefy Nezhad M, et al
    An Expert Overview on Therapies in Non-Transfusion-Dependent Thalassemia: Classical to Cutting Edge in Treatment.
    Hemoglobin. 2023;47:56-70.
    >> Share

  116. QIU Y, Wei S, Hou W, Lai K, et al
    Molecular Basis and Hematologic Phenotype of Hemoglobin H Disease Combined with Two Rare beta-Globin Mutations.
    Hemoglobin. 2023;47:52-55.
    >> Share

  117. ARAUJO ADS, Silva Pinto AC, Lobo CLC, Figueiredo MS, et al
    Novel Insights into the Pathophysiology and Treatment of Sickle Cell Disease.
    Hemoglobin. 2023;47:71-79.
    >> Share

  118. TANG HS, Xiong Y, Li DZ
    Fetal Hemoglobin H Hydrops Fetalis: Another Three Case Reports.
    Hemoglobin. 2023;47:102-104.
    >> Share

  119. LIU D, Nong C, Lai F, Tang Y, et al
    Research Progress of Cell-Free Fetal DNA in Non-Invasive Prenatal Diagnosis of Thalassemia.
    Hemoglobin. 2023;47:80-84.
    >> Share

  120. WU BD, Zhou XY, Xie MJ, Jin CC, et al
    Identification of a Novel 7-bp Deletion in the alpha-Globin Gene Cluster in One Chinese Family.
    Hemoglobin. 2023;47:49-51.
    >> Share

  121. LONG J, Gong F, Sun L, Yu C, et al
    A novel alpha Globin Gene Cluster Duplication, alphaalphaalphaalpha(380) Heterozygous beta(0)-Thal Variant, Leading to a Blood Transfusion-Dependent Phenotype.
    Hemoglobin. 2023;47:25-30.
    >> Share

  122. DEMIDOVA E, Salomashkina V, Selivanova D, Litvin E, et al
    Hb Ryazan: An Elongated C-Terminal beta-Chain Due to a New Frameshift Mutation, HBB: c.396delG p.Val133Trpfs*25.
    Hemoglobin. 2023;47:97-101.
    >> Share

  123. EGHBALI A, Ghaffari K, Shaykh Baygloo R, Eghbali A, et al
    Polyneuropathy Associated with Age of Starting the Transfusion and Serum Ferritin Level in Iranian Patients with Thalassemia Major and Intermedia.
    Hemoglobin. 2023;47:42-48.
    >> Share

  124. SEYDEL GS, Ayan D, Balci T, Bayraktar M, et al
    Prevalence of Hemoglobinopathies in Premarital Screening in the Province of Nigde, Turkey.
    Hemoglobin. 2023;47:36-41.
    >> Share

  125. ZHANG W, Han X, Deng J, Zhou R, et al
    Two Novel alpha-Thalassemia Mutations CD 39 -C [Thr > Pro] and CD 109 ACC > CCC [Thr > Pro] Identified in Two Chinese Families: A Case Report.
    Hemoglobin. 2023;47:172-179.
    >> Share

  126. XIAO ZQ, Jiang F, Li DZ
    beta-Thalassemia Trait Caused by SUPT5H Defects: Another Case Report.
    Hemoglobin. 2023;47:145-146.
    >> Share

  127. HAJIMOHAMMADI Z, Alimohammadi-Bidhendi S, Bagheri Amiri F, Karimipoor M, et al
    Development of a Quantitative Multiplex PCR to Detect Three Common Alpha Thalassemia Deletions.
    Hemoglobin. 2023;47:163-166.
    >> Share

  128. KHATER D, Al-Mulaabed S, Alomairi A, Elshinawy M, et al
    Effect of Hydroxyurea Therapy on Growth Parameters in Older Children (6-15 Year-Old) with Sickle Cell Disease: Low Dose Versus High Dose.
    Hemoglobin. 2023;47:157-162.
    >> Share

  129. 'ULYA NM, Indrawati VN, Wulansari WT, Lesmana I, et al
    Mutation Spectrum of beta-Globin Gene in Patients with beta-Thalassemia at Tidar Hospital, Magelang, Central Java, Indonesia.
    Hemoglobin. 2023;47:152-156.
    >> Share

  130. YILDIRIM AT, Gulen H, Turkmen H, Ozek G, et al
    Successful Treatment of a Child with Hemoglobin Hammersmith with Hematopoietic Stem Cell Transplantation.
    Hemoglobin. 2023;47:137-139.
    >> Share

  131. BAZAZZADEGAN N, Abedini SS, Azarkeivan A, Banihashemi S, et al
    The Spectrum of HBB Mutations among 2315 Beta Thalassemia Patients of a Reference Clinic in Tehran-Iran.
    Hemoglobin. 2023;47:147-151.
    >> Share

  132. BABU BV, Sharma Y, Sridevi P, Surti SB, et al
    Strengthening Health System and Community Mobilization for Sickle Cell Disease Screening and Management among Tribal Populations in India: An Interventional Study.
    Hemoglobin. 2023;47:227-236.
    >> Share

  133. HAMALI HA
    Hypercoagulability in Sickle Cell Disease: A Thrombo-Inflammatory Mechanism.
    Hemoglobin. 2023;47:205-214.
    >> Share

  134. MURAD H, Moassas F, Ali B, Katranji E, et al
    The Spectrum of alpha-Thalassemia Mutations in Syrian Patients.
    Hemoglobin. 2023;47:245-248.
    >> Share

  135. KEOWMANI T, Teo SC, Yap KC, Chua WL, et al
    Adherence to Iron Chelation Therapy Among Children with Beta Thalassemia Major: A Multicenter Cross-Sectional Study.
    Hemoglobin. 2023;47:237-244.
    >> Share

    September 2023
  136. GREWAL A, Kakkar S, Dewan P, Bansal N, et al
    Prevalence, Severity, and Determinants of Pain in Thalassemia.
    Hemoglobin. 2023;47:191-197.
    >> Share

  137. RASHID NW, Al-Allawi N, Tahir HI
    Silent Cerebral Infarcts in Iraqi Patients with Sickle Cell Disease.
    Hemoglobin. 2023;47:198-201.
    >> Share

  138. SINGH P, Shaikh S, Parmar S, Gupta R, et al
    Current Status of beta-Thalassemic Burden in India.
    Hemoglobin. 2023;47:181-190.
    >> Share

    July 2023
  139. ABU-ISMAIL L, Taha MJJ, Abuawwad MT, Al-Bustanji Y, et al
    COVID-19 and Anemia: What Do We Know So Far?
    Hemoglobin. 2023 Jul 31:1-8. doi: 10.1080/03630269.2023.2236546.
    >> Share

    May 2023
  140. LIU L, Fu Q, Zhang D, Chen D, et al
    Analysis of Mean Corpuscular Volume and Red Cell Distribution Width in Patients with Aplastic Anemia.
    Hemoglobin. 2023 May 10:1-5. doi: 10.1080/03630269.2023.2206575.
    >> Share

  141. AL-ZEBARI S, Al-Allawi NA, Nerweyi F
    Beta Globin Gene Cluster Haplotypes in Beta Thalassemia in the Kurdistan Region of Iraq.
    Hemoglobin. 2023;47:111-117.
    >> Share

  142. SHAMOON R, Yassin A, Charkaneh A
    Detection of a Rare Mutation in the Initiation Codon of the beta-Globin Gene (HBB:C.2T > C; P.Met1Thr).
    Hemoglobin. 2023;47:118-121.
    >> Share

  143. CHEN YP, Wu P, Wang H, Wu JF, et al
    A Rare Case of Abnormal Hemoglobin Variant Hb Mizuho: [HBB: c.206T > C beta 68(E12) Leu-Pro]: A First Report in the Chinese Population.
    Hemoglobin. 2023;47:130-134.
    >> Share

  144. KUMAR R, Ahmad SA, Ozdemir M, Sadayappan S, et al
    Mutation Spectrum of beta-Thalassemia in Some Ethnic Groups of North Maharashtra, India.
    Hemoglobin. 2023;47:105-110.
    >> Share

    January 2023
  145. PUROHIT P, Mohanty PK, Panigrahi J, Das K, et al
    Effect of alpha(+) Thalassemia on the Severity of Plasmodium falciparum Malaria in Different Sickle Cell Genotypes in Indian Adults: A Hospital-Based Study.
    Hemoglobin. 2023;47:11-18.
    >> Share

  146. KABIR T, Anwar S, Mourosi JT, Akter S, et al
    alpha- and beta-Globin Gene Mutations in Individuals with Hemoglobinopathies in the Chattogram and Sylhet Regions of Bangladesh.
    Hemoglobin. 2023;47:3-10.
    >> Share

  147. PAN L, Tian P, Chen S, Zhang R, et al
    Novel Promoter Mutation (HBB:C.-139_-138del) Associated with beta-Thalassemia Trait Detected by Next-Generation Sequencing in Southern China.
    Hemoglobin. 2023;47:21-24.
    >> Share

    November 2022
  148. WEN YJ, Yu QX, Jiang F, Li DZ, et al
    Identification of a Novel Mutation in the 3' Untranslated Region of the beta-Globin Gene (HBB:c.*132C>G) in a Chinese Family.
    Hemoglobin. 2022;46:347-350.
    >> Share

  149. GIAMBONA A, Leto F, Cassara F, Tartaglia V, et al
    Celocentesis for Early Prenatal Diagnosis in Couples at-Risk for beta-Thalassemia and Sicilian (deltabeta)(0)-Thalassemia.
    Hemoglobin. 2022;46:297-302.
    >> Share

  150. ELEFTHERIOU A, Antoniou E, Darba J, Ascanio M, et al
    Estimating the Cost of Thalassemia Care across the World: A Thalassemia International Federation Model.
    Hemoglobin. 2022;46:308-311.
    >> Share

  151. WU SM, Huang SR, Li C, Chen GL, et al
    Severe Hb H Disease Caused by Hb Zurich-Albisrieden (HBA1: c.178G>C): Another Case Report.
    Hemoglobin. 2022;46:341-343.
    >> Share

  152. SUALI L, Mohammad Salih FA, Ibrahim MY, Jeffree MSB, et al
    Genotype-Phenotype Study of beta-Thalassemia Patients in Sabah.
    Hemoglobin. 2022;46:317-324.
    >> Share

  153. ASMARIAN N, Kamalipour A, Hosseini-Bensenjan M, Karimi M, et al
    Prediction of Heart and Liver Iron Overload in beta-Thalassemia Major Patients Using Machine Learning Methods.
    Hemoglobin. 2022;46:303-307.
    >> Share

  154. GUAN ZY, Zhong ZY, Xu ZB, Chen JH, et al
    A Case of Misdiagnosis Caused by the Coinheritance of Hb G-Siriraj [beta7(A4)Glu-->Lys; HBB: c.22G>A] and Hb H Disease.
    Hemoglobin. 2022;46:338-340.
    Lys; HBB: c.22G>A] and Hb H Disease.&body=GUAN ZY, Zhong ZY, Xu ZB, Chen JH, et al. A Case of Misdiagnosis Caused by the Coinheritance of Hb G-Siriraj [beta7(A4)Glu-->Lys; HBB: c.22G>A] and Hb H Disease. Hemoglobin. 2022;46:338-340. https://pubmed.ncbi.nlm.nih.gov/36691989" ALT="Email" TITLE="Email"> --> >> Share

  155. LONG J, Gong F, Sun L, Lai G, et al
    Identification of Three Families Carrying Hb Anti-Lepore Hong Kong Variant in Guangxi, China, and Analysis of Their Hematological Data.
    Hemoglobin. 2022;46:325-329.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016